Search General Info
Search Education
Search Partnering Companies

FYR Diagnostics

Missoula, MT, United States of America
FYR Diagnostics is developing a powerful portfolio of novel biomarker panels for various diseases, as well as detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, diagnosis, and management of human and agricultural diseases. We are currently using novel platforms and technologies to develop next generation biomarkers for applications in human health such as cancers, neurodegenerative conditions, and pathogenic diseases. We are also applying these technologies to develop biomarkers for diseases in agriculture.

FYR Diagnostics is also an accredited CLIA (Clinical Laboratory Improvement Amendments) licensed laboratory specializing in high-complexity diagnostic testing for COVID-19. Our current testing methodology utilizes RT-PCR technology approved for Emergency Use Authorization by the FDA coupled with an advanced automation platform.